Answers are grounded in this paper and cite their sources.
Tc-nanocolloid in prostate cancer improves detection of positive nodes and potentially lowers recurrence rates with subsequent optimization of patient management, without harming patient safety.
No takes yet. Share an insight, caveat, or question.
Mazzone et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: